TABLE 2.
Summary of baseline characteristics and outcome in 20 patients with SAH after endovascular revascularization.
| Case | Age/ Sex |
Baseline NIHSS |
Clot Location |
Risk Factors | Modality | Hemorrhage | Collateral Flow |
TIMI II/III |
AOL II/III |
Procedure Complication |
Neurologic Deterioration |
mRS |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 72/M | 22 | MCA M1 | HTN, CAD | MERCI | SAH, grade 2 | Excellent | Yes | Yes | NO | NO | 5 |
| 2 | 64/M | 18 | MCA M1 | HTN, CAD, DM, Afib, Smoking, Aspirin use | MERCI | SAH, grade 2 | Absence | Yes | Yes | NO | NO | 4 |
| 3 | 47/F | 19 | ICA | HTN, Afib, Warfarin use | MERCI | SAH, grade 2; PH-2 | Excellent | NO | NO | Vessel perforation with wire | NO | 4 |
| 4 | 49/M | 7 | MCA M2 | HTN, Afib, Aspirin use | MERCI | SAH, grade 2; HI-1 | Moderate | NO | NO | CE after MERCI | NO | 1 |
| 5 | 38/F | 18 | MCA M1 | DM, DL, Prior iCVA, MVR, Warfarin use | MERCI | SAH, grade 2 | Moderate | NO | NO | Supraclinoid ICA dissection after MERCI | NO | 4 |
| 6 | 44/F | 8 | MCA M1 | HTN, DM, PVD | MERCI | SAH, grade 3; HI-2 | Excellent | Yes | Yes | NO | Yes | 4 |
| 7 | 46/F | 4 | MCA M1 | MVR | IV+MERCI | SAH, grade 2 | Excellent | NO | NO | NO | NO | 3 |
| 8 | 39/F | 12 | MCA M1 | Smoking | IV+MERCI | SAH, grade 2 | Excellent | NO | NO | CE after MERCI | NO | 4 |
| 9 | 86/F | 24 | MCA M1 | HTN, DM, Afib | IV+MERCI | SAH, grade 3; PH-2 | Excellent | Yes | Yes | CE after MERCI | NO | 4 |
| 10 | 50/F | 16 | MCA M1 | HTN, Smoking, Afib | IV+MERCI | SAH, grade 2; HI-1 | Excellent | Yes | Yes | NO | NO | 3 |
| 11 | 84/F | 25 | MCA M1 | HTN, DL, Afib, Prior iCVA | IV+MERCI | SAH, grade 2 | Moderate | Yes | Yes | NO | NO | 3 |
| 12 | 84/M | 24 | MCA M1 | HTN, CAD, Afib, Prior iCVA | IA+MERCI | SAH, grade 2; PH-2 | Excellent | Yes | Yes | Vessel perforation with wire | Yes | 6 |
| 13 | 87/F | 28 | ICA | HTN, CAD, pacemaker | MERCI+MCA angioplasty | SAH, grade 2; HI-2 | Absence | NO | NO | NO | NO | 6 |
| 14 | 74/M | 15 | MCA M1 | HTN, CAD, DM, DL, Afib, Warfarin use, MVR | MERCI+MCA angioplasty | SAH, grade 2; PH-1 | Moderate | Yes | Yes | NO | NO | 6 |
| 15 | 88/F | 25 | MCA M1 | HTN, DM, Afib, Aspirin use | IV+MERCI+ MCA angioplasty | SAH, grade 2; PH-2 | Moderate | NO | NO | NO | NO | 6 |
| 16 | 65/M | 25 | MCA M1 | HTN, DL, Smoking, | IV+MERCI+MCA angioplasty | SAH, grade 2 | Moderate | Yes | Yes | MCA dissection after angioplasty | NO | 5 |
| 17 | 58/M | 11 | ICA | HTN, PVD, Proximal stenosis, Aspirin use | MERCI+CAS | SAH, grade 2 | Moderate | Yes | Yes | Merci device fracture | NO | 4 |
| 18 | 85/M | 24 | ICA | HTN, DM, pacemaker | MERCI+Microsnare | SAH, grade 2; HI-2 | Absence | Yes | Yes | Merci device fracture | NO | 6 |
| 19 | 42/M | 15 | MCA M2 | HTN, Proximal stenosis, Afib | IV+IA | SAH, grade 2; HI-2 | Moderate | Yes | Yes | NO | NO | 1 |
| 20 | 76/F | 10 | MCA M2 | HTN, Afib, Prior iCVA | IV+IA | SAH, grade 2; PH-2 | Moderate | NO | NO | NO | NO | 3 |
Afib indicates atrial fibrillation; CAD, coronary artery disease; CAS, carotid artery stenting; CE, contrast extravasation; DL, dyslipidemia; DM, diabetes mellitus; HTN, hypertension; IA, intraarterial; ICA, internal carotid artery; iCVA, ischemic cerebrovascular accident; IV, intravenous; MCA, middle cerebral artery; MERCI, mechanical clot retrieval therapy; mRS, modified rankin scale; MVR, mitral valve replacement; PVD, peripheral vascular disease.